Litcius/Paper detail

Primary outcome analysis of invasive disease-free survival for monarchE: abemaciclib combined with adjuvant endocrine therapy for high risk early breast cancer

JAO'Shaughnessy O'Shaughnessy, SJohnston Johnston, NHarbeck Harbeck, MToi Toi, YHIm Im, MReinisch Reinisch, ZMShao Shao, Plk Lehtinen, CSHuang Huang, A. Tryakin, MGoetz Goetz, HSRugo Rugo, ESenkus Senkus, LTesta Testa, MAndersson Andersson, KTamura Tamura, GGSteger Steger, LDel Mastro Del Mastro, JCox Cox, TForrester Forrester, SSherwood Sherwood, XLLi Li, RWei Wei, MMartin Martin, PRastogi Rastogi

2021Cancer Research11 citations

Topics & Concepts

MedicineOncologyBreast cancerCancerInternal medicineAdjuvantAdjuvant therapyEndocrine systemDiseaseGynecologyHormoneAdvanced Breast Cancer TherapiesLung Cancer Research Studies
Primary outcome analysis of invasive disease-free survival for monarchE: abemaciclib combined with adjuvant endocrine therapy for high risk early breast cancer | Litcius